Skip to main content
Erschienen in: Japanese Journal of Radiology 6/2023

06.01.2023 | Original Article

Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis

verfasst von: Beidi Jia, David Lim, Yisha Zhang, Chao Dong, Zhihui Feng

Erschienen in: Japanese Journal of Radiology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Breast cancer is the most common malignant tumor in women. Radiotherapy (RT) is an important adjunctive therapy for breast cancer, but the current international research trend of RT in breast cancer treatment and management is unclear. This bibliometric analysis was conducted to investigate the current trends and hot topics in this area.

Materials and methods

The Web of Science Core Collection (WoSCC; Clarivate) database was searched, VOSviewer 1.6.18 and CiteSpace 6.1.R2 software were employed for the quantitative and qualitative analysis.

Results

12,268 publications were included in this bibliometric analysis. There was an increasing trend of publications and international collaborations in the topic. The United States and The University of Texas MD Anderson Cancer Center were the most productive countries and institutions, respectively. The analysis of journals showed researches focused on both basic and clinical medicine on breast cancer RT. Park Won published the most papers and Fisher B had the most co-citations. The most co-cited paper was published in the Lancet. Survival, risk, chemotherapy, mastectomy, and surgery were regarded as current research hotspots through the analysis of keywords.

Conclusion

Through quantitative and qualitative bibliometric analyses, this study provides insights into the research trends and potential research hotspots on breast cancer RT.
Literatur
1.
Zurück zum Zitat Thompson JL, Wright GP. The role of breast MRI in newly diagnosed breast cancer: an evidence-based review. Am J Surg. 2021;221:525–8.PubMedCrossRef Thompson JL, Wright GP. The role of breast MRI in newly diagnosed breast cancer: an evidence-based review. Am J Surg. 2021;221:525–8.PubMedCrossRef
2.
3.
Zurück zum Zitat Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010;11:339–49.PubMedCrossRef Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010;11:339–49.PubMedCrossRef
4.
Zurück zum Zitat Zhang YN, Xia KR, Li CY, Wei BL, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764.PubMedPubMedCentral Zhang YN, Xia KR, Li CY, Wei BL, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764.PubMedPubMedCentral
5.
Zurück zum Zitat Ashwanikumar N, Plaut JS, Mostofian B, Patel S, Kwak P, Sun C, et al. Supramolecular self assembly of nanodrill-like structures for intracellular delivery. J Control Release. 2018;282:76–89.PubMedPubMedCentralCrossRef Ashwanikumar N, Plaut JS, Mostofian B, Patel S, Kwak P, Sun C, et al. Supramolecular self assembly of nanodrill-like structures for intracellular delivery. J Control Release. 2018;282:76–89.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Suppl 1):9S-16S.PubMedCrossRef McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Suppl 1):9S-16S.PubMedCrossRef
7.
Zurück zum Zitat Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–26.PubMedCrossRef Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–26.PubMedCrossRef
8.
Zurück zum Zitat Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, et al. Breast cancer version 3.2014. J Natl Compr Canc Netw. 2014;12:542–90.PubMedCrossRef Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, et al. Breast cancer version 3.2014. J Natl Compr Canc Netw. 2014;12:542–90.PubMedCrossRef
9.
Zurück zum Zitat Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010:162–77.PubMedCrossRef Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010:162–77.PubMedCrossRef
10.
Zurück zum Zitat Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.PubMedCrossRef Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.PubMedCrossRef
11.
Zurück zum Zitat McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15.PubMedPubMedCentralCrossRef McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Green MD, Brenneman R, Powell SN, Bergom C. Harnessing the DNA repair pathway in breast cancer: germline mutations/polymorphisms in breast radiation. Semin Radiat Oncol. 2022;32:298–302.PubMedCrossRef Green MD, Brenneman R, Powell SN, Bergom C. Harnessing the DNA repair pathway in breast cancer: germline mutations/polymorphisms in breast radiation. Semin Radiat Oncol. 2022;32:298–302.PubMedCrossRef
14.
Zurück zum Zitat Verma S, Gustafsson A. Investigating the emerging COVID-19 research trends in the field of business and management: a bibliometric analysis approach. J Bus Res. 2020;118:253–61.PubMedPubMedCentralCrossRef Verma S, Gustafsson A. Investigating the emerging COVID-19 research trends in the field of business and management: a bibliometric analysis approach. J Bus Res. 2020;118:253–61.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Donthu N, Kumar S, Pandey N. A retrospective evaluation of marketing intelligence and planning: 1983–2019. Mark Intell Plan. 2021;39:48–73.CrossRef Donthu N, Kumar S, Pandey N. A retrospective evaluation of marketing intelligence and planning: 1983–2019. Mark Intell Plan. 2021;39:48–73.CrossRef
16.
Zurück zum Zitat Donthu N, Kumar S, Pandey N, Lim WM. Research constituents, intellectual structure, and collaboration patterns in journal of international marketing: an analytical retrospective. J Int Mark. 2021;29:1–21.CrossRef Donthu N, Kumar S, Pandey N, Lim WM. Research constituents, intellectual structure, and collaboration patterns in journal of international marketing: an analytical retrospective. J Int Mark. 2021;29:1–21.CrossRef
17.
Zurück zum Zitat Zhang Y, Lim D, Yao Y, Dong C, Feng Z. Global research trends in radiotherapy for gliomas: a systematic bibliometric analysis. World Neurosurg. 2022;161:e355–62.PubMedCrossRef Zhang Y, Lim D, Yao Y, Dong C, Feng Z. Global research trends in radiotherapy for gliomas: a systematic bibliometric analysis. World Neurosurg. 2022;161:e355–62.PubMedCrossRef
18.
Zurück zum Zitat Das JP, Thulasidasan N, Ahmed I, Diamantopoulos A. Transarterial chemoembolization for hepatocellular carcinoma: a bibliometric analysis of the most cited articles. Jpn J Radiol. 2020;38:1190–6.PubMedCrossRef Das JP, Thulasidasan N, Ahmed I, Diamantopoulos A. Transarterial chemoembolization for hepatocellular carcinoma: a bibliometric analysis of the most cited articles. Jpn J Radiol. 2020;38:1190–6.PubMedCrossRef
19.
Zurück zum Zitat Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.PubMedCrossRef Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.PubMedCrossRef
20.
Zurück zum Zitat Mulet-Forteza C, Genovart-Balaguer J, Merigo JM, Mauleon-Mendez E. Bibliometric structure of IJCHM in its 30 years. Int J Contemp Hosp Manag. 2019;31:4574–604.CrossRef Mulet-Forteza C, Genovart-Balaguer J, Merigo JM, Mauleon-Mendez E. Bibliometric structure of IJCHM in its 30 years. Int J Contemp Hosp Manag. 2019;31:4574–604.CrossRef
21.
Zurück zum Zitat Gao Y, Shi SZ, Ma WJ, Chen J, Cai YT, Ge L, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374–84.PubMedCrossRef Gao Y, Shi SZ, Ma WJ, Chen J, Cai YT, Ge L, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374–84.PubMedCrossRef
22.
Zurück zum Zitat D’Arcangelo D, Giampietri C, Facchiano F, Facchiano A. BAMM: a preliminary bibliometric analysis on melanoma manuscripts. Pigment Cell Melanoma Res. 2013;26:415–7.PubMedCrossRef D’Arcangelo D, Giampietri C, Facchiano F, Facchiano A. BAMM: a preliminary bibliometric analysis on melanoma manuscripts. Pigment Cell Melanoma Res. 2013;26:415–7.PubMedCrossRef
23.
Zurück zum Zitat Huang TJ, Wu HY, Yang SD, Su B, Tang K, Quan ZX, et al. Global trends of researches on sacral fracture surgery a bibliometric study based on VOSviewer. Spine. 2020;45:E721–8.PubMedCrossRef Huang TJ, Wu HY, Yang SD, Su B, Tang K, Quan ZX, et al. Global trends of researches on sacral fracture surgery a bibliometric study based on VOSviewer. Spine. 2020;45:E721–8.PubMedCrossRef
24.
Zurück zum Zitat Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRef Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.CrossRef
25.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRef Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRef
26.
Zurück zum Zitat Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.PubMedCrossRef Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.PubMedCrossRef
27.
Zurück zum Zitat McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.PubMedCrossRef McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.PubMedCrossRef
28.
Zurück zum Zitat Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRef
29.
Zurück zum Zitat Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.PubMedCrossRef Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.PubMedCrossRef
30.
Zurück zum Zitat Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.PubMedCrossRef Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.PubMedCrossRef
31.
Zurück zum Zitat Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.PubMedCrossRef Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.PubMedCrossRef
32.
Zurück zum Zitat Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.PubMedCrossRef Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.PubMedCrossRef
33.
Zurück zum Zitat Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.PubMedCrossRef Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.PubMedCrossRef
34.
Zurück zum Zitat Mc WR. The principles of treatment by radiotherapy in breast carcinoma. Br J Cancer. 1950;4:368–71.CrossRef Mc WR. The principles of treatment by radiotherapy in breast carcinoma. Br J Cancer. 1950;4:368–71.CrossRef
35.
Zurück zum Zitat Miglietta F, Griguolo G, Guarneri V, Dieci MV. Programmed cell death ligand 1 in breast cancer: technical aspects, prognostic implications, and predictive value. Oncologist. 2019;24:E1055–69.PubMedPubMedCentralCrossRef Miglietta F, Griguolo G, Guarneri V, Dieci MV. Programmed cell death ligand 1 in breast cancer: technical aspects, prognostic implications, and predictive value. Oncologist. 2019;24:E1055–69.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Kodonas K, Fardi A, Gogos C, Economides N. Scientometric analysis of vital pulp therapy studies. Int Endod J. 2021;54:220–30.PubMedCrossRef Kodonas K, Fardi A, Gogos C, Economides N. Scientometric analysis of vital pulp therapy studies. Int Endod J. 2021;54:220–30.PubMedCrossRef
38.
Zurück zum Zitat DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.PubMedCrossRef DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.PubMedCrossRef
39.
Zurück zum Zitat Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–7.PubMedCrossRef Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–7.PubMedCrossRef
40.
Zurück zum Zitat He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, et al. Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies. Crit Rev Oncol Hematol. 2018;131:96–101.PubMedCrossRef He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, et al. Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies. Crit Rev Oncol Hematol. 2018;131:96–101.PubMedCrossRef
41.
Zurück zum Zitat Ning WJ, Liu X, Zeng HY, An ZQ, Luo WX, Xia NS. Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opin Drug Deliv. 2022;19:815–32.PubMedCrossRef Ning WJ, Liu X, Zeng HY, An ZQ, Luo WX, Xia NS. Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opin Drug Deliv. 2022;19:815–32.PubMedCrossRef
43.
Zurück zum Zitat Bennion NR, Baine M, Granatowicz A, Wahl AO. Accelerated partial breast radiotherapy: a review of the literature and future directions. Gland Surg. 2018;7:596–610.PubMedPubMedCentralCrossRef Bennion NR, Baine M, Granatowicz A, Wahl AO. Accelerated partial breast radiotherapy: a review of the literature and future directions. Gland Surg. 2018;7:596–610.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597–608.PubMedCrossRef Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597–608.PubMedCrossRef
45.
Zurück zum Zitat Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, et al. Association of transforming growth factor beta polymorphism C-509T with radiation-induced fibrosis among patients with early-stage breast cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4:1751–7.PubMedPubMedCentralCrossRef Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, et al. Association of transforming growth factor beta polymorphism C-509T with radiation-induced fibrosis among patients with early-stage breast cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4:1751–7.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Woo J, Moon BI, Kwon H, Lim W. Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study. Sci Rep. 2022;12:10729.PubMedPubMedCentralCrossRef Woo J, Moon BI, Kwon H, Lim W. Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study. Sci Rep. 2022;12:10729.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Cao L, Xu C, Cai G, Qi WX, Cai R, Wang SB, et al. How does the interval between completion of adjuvant chemotherapy and initiation of radiotherapy impact clinical outcomes in operable breast cancer patients? Ann Surg Oncol. 2021;28:2155–68.PubMedCrossRef Cao L, Xu C, Cai G, Qi WX, Cai R, Wang SB, et al. How does the interval between completion of adjuvant chemotherapy and initiation of radiotherapy impact clinical outcomes in operable breast cancer patients? Ann Surg Oncol. 2021;28:2155–68.PubMedCrossRef
48.
Zurück zum Zitat Woodward SG, Varshney K, Anne PR, George BJ, Willis AI. Trends in use of hypofractionated whole breast radiation in breast cancer: an analysis of the national cancer database. Int J Radiat Oncol Biol Phys. 2021;109:449–57.PubMedCrossRef Woodward SG, Varshney K, Anne PR, George BJ, Willis AI. Trends in use of hypofractionated whole breast radiation in breast cancer: an analysis of the national cancer database. Int J Radiat Oncol Biol Phys. 2021;109:449–57.PubMedCrossRef
49.
Zurück zum Zitat Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8:145–52.PubMedCrossRef Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8:145–52.PubMedCrossRef
Metadaten
Titel
Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis
verfasst von
Beidi Jia
David Lim
Yisha Zhang
Chao Dong
Zhihui Feng
Publikationsdatum
06.01.2023
Verlag
Springer Nature Singapore
Erschienen in
Japanese Journal of Radiology / Ausgabe 6/2023
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-022-01383-x

Weitere Artikel der Ausgabe 6/2023

Japanese Journal of Radiology 6/2023 Zur Ausgabe

Letter to the Editor

Letter to the Editor

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.